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Theincidenceofpretermbirthindevelopedcountrieshasriseninthepastdecades.Underlyingcausesforthisenigmaticpregnancy
complicationarenumerous,yetinfectiousagentsthatinducedysregualtionofimmunityatthematernal-fetalinterfaceposeoneof
themostprobablecausesofpretermbirth.Thispaperhighlightstwofactorsregardingmaternalinfectionsthattriggerunscheduled
inﬂammatory sequences that are deleterious to the maternal-fetal balance necessary to maintain pregnancy. Firstly, we discuss the
role of Toll-like receptors (TLRs) as sentinels of uterine immunity in the context of response to pathogens. We highlight the idea
that particular TLR activations lead to diﬀerential immune cascades that induce preterm birth. Secondly, two alternative routes of
pathogenic entry may prove to be critical for inducing preterm birth via a cytokine storm or a secondary and currently unknown
cell-mediatedmechanismofuterineinﬂammation.Thispapersummarizespathwaysthatunderlieactivationofadverseanddiverse
immune responses to foreign agents that may result in preterm birth.
1.Introduction
Healthy pregnancy is the result of a tightly regulated system
of crosstalk between maternal and fetal structures. Implan-
tation and parturition are speciﬁcally characterized by states
of inﬂammation [1, 2]. Proinﬂammatory cytokines, matrix
degradingproteins,alteredtranscriptionalfactors,rapidhor-
monal changes, and immune cell activity are paramount for
uterine activation and the onset of labor [3]. In contrast, the
gestation period, comprised of decidualization, placentation,
and fetal development, requires uterine quiescence guided
by high levels of progesterone and the production of anti-
inﬂammatory cytokines from both maternal and fetal cells
[4, 5]. Due to the immediacy with which the onset of
labor takes place and the resultant necessary shift from
anti- to proinﬂammatory signal cascades, it is not surprising
that unscheduled parturition is the most high risk state of
pregnancy for adverse outcomes.
Preterm birth can result from a range of causes such
as exposure to environmental triggers, maternal stress, fetal
or maternal genetic abnormalities, or hormonal imbalance.
However, infection is one of the most heralded causes of
preterm birth due to the drastic link between underlying
infectious agents and their ability to promote inﬂammatory
responses [6–8]. It is well documented that the vast majority,
upwards of 90% of preterm births that occur before gesta-
tional week 28 can be correlated to the presence of infectious
agents and severe inﬂammation [9]. Furthermore, a signif-
icant number of placentas obtained from preterm deliveries
showpathologicalsignsofchorioamnionitiswhichcanresult
from a number of diﬀerential pathogenic agents [10]. Thus,
while the evidence for infection-mediated preterm birth is
substantial, the underlying mechanisms that induce early
birth in response to pathogenic presence remain vague.
Investigation into the mechanisms that lead to preterm
birth in response to pathogenic agents should take into
account several key factors. Firstly, the route of entry that
a given foreign agent takes determines where the agent
will ultimately subsist and what pathways will be activated.
Recent evidence demonstrates that the same pathogen,
delivered through alternative routes, can lead to diﬀer-
ential inﬂammatory responses ([11–13], our unpublished
results). Therefore, the mechanisms that underlie initiation
of preterm birth may be dependent on the organ or tissue
where a pathogen enters. Secondly, diﬀerent pathogens may
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and animal models show that alternative sets of cytokines
coupledwithactivationofmaternalorfetalcellsaretriggered
in response to diﬀerent pathogenic agents, yet all result in
unscheduled inﬂammation [14, 15]. A strong explanation
for initiation of distinct immune pathways is probably the
activation of toll-like receptors (TLRs). TLRs are a diverse
set of innate immune sentinel receptors highly conserved
throughout evolution. Each TLR1–10 is speciﬁc for a dif-
ferent pathogen associated molecular pattern (PAMP) [16].
Importantly, TLRs are highly expressed at the maternal-fetal
interface on trophoblasts and uterine immune cells [17]. It is
likely that diﬀerential uterine immune responses occur due
tothediversityofpathogensthatensuesactivationofanyone
of the TLRs, ultimately leading to deleterious inﬂammation
and preterm birth.
This paper aims to summarize speciﬁc viral and bacterial
pathogens that may program preterm birth outcomes. Fur-
thermore, we expound upon possible routes of transmission
and areas of replication that diﬀerent foreign organisms may
hometo.Finally,afterabriefdiscussionofthenecessarysteps
toward an inﬂammatory environment that programs term
labor,weelaborateonpathogenictriggersofthis processthat
may activate TLRs to induce preterm birth.
2.KeystoParturition
In order to delineate the aberrant induction of inﬂammation
by infectious agents, the role of inﬂammation in healthy
pregnancy outcomes must be understood. The act of birth is
characterized by the onset of uterine contractions that lead
to expulsion of the fetus from the uterine cavity. The act
of giving birth is the ultimate step in a proinﬂammatory
signaling cascade that is orchestrated by an intrauterine
milieu coupled to hormonal cues.
Temporalincreaseininﬂammatorysignalsinitiateslabor.
Inﬂammatory cytokines and chemokines such as TNF-α,
IL-1β and IL-8 increase in the placental microenvironment,
including amniotic ﬂuid and fetal membranes. This induces
signals for innate immune cells to become activated [18, 19].
Upon initiation of a proinﬂammatory cascade including
NF-κB activation, uterine immune cells produce inﬂamma-
tory chemokines and cytokines. Increased uterine activation
of transcription by NF-κB leads directly to high levels of
COX-2, PGE2, the gap junction protein connexin 43, and
upregulation of the oxytocin receptor [20]. The increase of
the aforementioned proteins and receptors leads to active
uterine stretching and thus to the induction of birth.
The pregnant uterus is replete with specialized immune
cells primed to play roles in implantation, placentation,
and parturition. The major cell types studied thus far
are uterine NK cells (uNK), dendritic cells, T regulatory
cells (Treg), and macrophages. uNK cells are the most
thoroughly studied uterine immune cells due to lack of
their natural cytotoxicity, an alternative receptor repertoire
to peripheral blood counterparts, and the ability to produce
vascular growth factors, cytokines, and chemokines during
early stages of pregnancy [21, 22]. In humans, uNK cells
are reduced after the second trimester. This trend is also
followed in mice. However, uNK cells can be ampliﬁed in
mice in response to inﬂammatory triggers at later stages
of pregnancy. It is thus tempting to speculate that such
a phenomenon may also occur in humans. Research has
expanded to investigate the ability of uNK cells to create a
balanced milieu at the maternal-fetal interface due to their
ability to produce IL-10, IP10, and IL-8 during cross-talk
with trophoblasts and dendritic cells [23–35]. uNK cells are
found interwoven throughout decidual areas where spiral
arteries are bountiful. This positioning is demonstrative of
their role in growth and decidualization of the placental
organ [22]. uNK cells peak in humans in ﬁrst trimester
and their numbers start to decrease at the end of second
trimester. Mouse models deﬁcient in uNK cells show that
properbirthtakesplaceintheabsenceofthesecells;however,
the placentation that occurs is shallow and less developed
than models where uNK cells are available [26]. While uNK
cellsarenotthoughttoplayadirectroleintermbirth,several
murine studies have shown that these cells can become
cytotoxic in nature in the presence of certain pathogens and
ultimatelyleadtopretermbirththroughproductionofTNF-
α [13, 14]. Thus, it stands to reason that the disappearance of
uNK cells in mid-third trimester is a fail-safe mechanism for
the course of term birth that allows the uterus to minimize
unscheduled inﬂammatory events.
While uNK cells do not play a documented role in
term birth, macrophages may hold the key to conduction
of proper parturition. Uterine macrophages are found in
proportions upwards of 20% of the total uterine lym-
phocyte population. Over the course of pregnancy, uter-
ine macrophages are present as innate immune sentinels
due to their expression of TLRs. However, macrophages
are immunomodulatory over the course of gestation as
they simultaneously produce TNF-α, IL-10, and TGF-β
throughout placentation [27]. Along similar lines, matrix
metalloproteinases (MMPs) are secreted in early and late
gestation for tissue degradation which in turn induces MIP-
1α and MCP-1 to signal the further invasion of macrophages
for phagocytosis [28–30]. Reports show that late stage stim-
ulation of uterine macrophages induces high levels of IL-8
production, a neutrophil and macrophage chemoattractant.
In line with these ﬁndings, the act of parturition itself is
associated with high levels of macrophage and neutrophil
inﬁltrationasthesetwocelltypescanquicklyengulf,remove,
and remodel tissue [31].
The function and phenotype of dendritic cells in the
uterus is beginning to be expounded upon. Recent studies
have highlighted their role in crosstalk with uNK cells and
trophoblasts in order to orchestrate production of cytokines
such as TNF-α, IL-12, and IL-10 [32]. While the role of
DCs in parturition remains unknown, it is fair to assume
that these cells add to the balanced cytokine and signaling
milieu required throughout gestation. Furthermore, recent
characterization in mice of a uterine-speciﬁc subset of DCs
that is skewed toward production of IL-15 and CCL6 adds to
evidencethattheiractionsaredichotomous[33].Thus,while
these cells contribute to an immunosuppressive atmosphere
over the course of gestation, they possess the capacity to
contribute to proinﬂammatory responses upon pathogenic
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While uNK cells, macrophages, and dendritic cells aid to
orchestrate the balance between pro- and anti-inﬂammatory
milieu over the course of gestation, T regulatory cells Tregs
in the uterus are thought to be mainly immunosuppressive.
Studiesdemonstratetheimportanceofthesecellsasadoptive
transferofTregsintoabortionpronemiceleadstopregnancy
rescue [34]. T-cell-deﬁcient Rag1−/− mice given the TLR4
agonistLPSdeliverpreterm.InfusionofTregsintothesemice
rescues pregnancy to term, indicating an advantageous role
forthesecellsinTLR-pathogenmediatedresponsetoadverse
pregnancy outcomes [35]. The function and phenotype of T
regs found in the uterus remains unknown, but these cells
are presenting as a possible therapeutic cell to aid in rescue
of pregnancy loss.
While the aforementioned cellular activities are highly
orchestrated throughout pregnancy and particularly during
the onset of labor, these actions are correlated to speciﬁc
hormonal cues that allow for these changes. For the majority
of pregnancies one of the main mechanisms that allows for
uterine quiescence and lack of uterine muscle movement is
theincreasedpresenceofthehormoneprogesterone[36,37].
Female sex hormones have been shown to decrease the T-
cell stimulatory capacity of DCs during pregnancy [38].
In rodents, direct treatment of DCs with progesterone has
been shown to increase the inhibitory capacity of DCs and
these changes are associated with progesterone receptor (PR)
regulation.DuetothefactthathumanandmurineuNKcells
do not possess PRs, the capacity of DCs to produce IL-15
for uNK development may work through indirect mediation
of DCs by progesterone [39, 40]. Importantly, macrophages
possess PRand aredirectlyregulatedbyprogesteroneastheir
migration and nitric oxide production is severely impaired
when progesterone levels are high. In support of these
ﬁndings, PR/ m i c es h o wh i g hl e v e l so fm a c r o p h a g ea n d
neutrophil inﬁltration in the pregnant uterus [3]. Taken
together,thefunctionalwithdrawalofprogesteroneiscritical
to the initiation of parturition as its decreased action allows
for control of immune cells needed to initiate inﬂammatory
cascades to be relinquished.
3.PretermBirth: ActivatedUterineImmunity
How does the presence of viral or bacterial organisms
lead to preterm birth? It is rarely the foreign organism
itself that causes preterm birth. Rather, it is the immune
response of the host evoked by the pathogen that leads
to aberrant pregnancy outcomes. With the knowledge
of parturition as a process mediated by inﬂammation,
we can begin to understand that pathogenic insults can
trigger unscheduled uterine immunity. Evidence demon-
strates that the activated TLR pathways and the route
of pathogenic entry may determine the immunological
cascade of aberrant cellular and cytokine activity that lead
to preterm birth ([11–15], our unpublished data). The
majority of these pathways commonly lead to increased
NF-κB activity that allows for production of inﬂamma-
tory cytokines and mediation of progesterone withdrawal
through modulation of the participation of diﬀerent PRs
[20].
Brieﬂy,theimmunesystematthematernal-fetalinterface
thus far has been discussed due to its virtue as specialized
toward growth and decidualization of the placental organ
and delicately regulated by sex hormones. However, new
observations have deciphered that innate immune defenses,
characteristic of innate immunity on peripheral blood cells,
are present at the placental level as well. The TLRs are
expressed at the placental level on trophoblasts, uNK cells,
DCs, and macrophages [17, 21]. Activation of any of the
TLRs leads to a downstream cascade of proinﬂammatory
cytokine production, and most notably, to activation of the
NF-κB transcription factor. It stands to reason that TLR
activation at the maternal-fetal interface may tip the tightly
regulated cytokine and hormonal anti-inﬂammatory milieu
necessary for successful term pregnancy.
Two forms of pathogenic entry are studied in rodent
models due to their correlations with human infection.
Intrauterineascensionthroughthevaginaltractandsystemic
inﬁltration are mimicked by intrauterine infusion and
intraperitoneal injections, respectively (Figure 1). Bacteria
show stronger correlations throughout the literature with
increased incidence of preterm birth than viruses. This
may be due to the diﬀerential sites of infection that
bacteria versus viruses target. Generally, bacteria are found
in mucosal membranes that surround the amniotic sac
or those lining the intrauterine canal [8]. On the other
hand, reports demonstrate that viruses, in need of host cell
machinery for replication, tend to infect trophoblast cells of
the placenta as these cells possess speciﬁc receptors needed
for viral particle entry [41–43]. Importantly, bacteria are
easily cultured from amniotic ﬂuid or from swab samples
taken from the uterine tracts of pregnant women [7, 44].
Due to the nature of viruses, these pathogens are more
diﬃcult to pinpoint, though some studies have been able
to isolate HIV and adenovirus from amniotic ﬂuid samples
[8, 45].
4. BacterialEntry
Bacterial infections manifest in the pregnant uterus generally
between maternal and fetal membranes or directly within
amnion or chorion speciﬁc fetal membranes. Infection of
the amniotic cavity is denoted amnionitis, direct infection
of fetal membranes is denoted chorioamnionitis; whereas
funisitis is infection of the umbilical cord. Interestingly,
several reports note that bacterial agents are rarely found at
the placental level, in contrast to viral pathogens [7, 8, 45].
Duetothefactthatbacteriacansubsistextracellularlywithin
membranes, it is reasonable to postulate that intrauterine
bacteria or fetal DNA due to necrosis of fetal cells are
visualizedbyTLRsthatareextracellularsuchasTLR2,TLR4,
TLR5, and TLR6 [46, 47].
Eﬀective methods of probing for the presence of bacterial
agents are immunostaining of membranes of the chorion
or amnion from term versus preterm deliveries. Membranes
from preterm delivered placentas show higher levels of
chemotactic proteins MCP-1 and CXCL6 (Granulocyte
chemotacticprotein-2),inﬂammatorycytokinesIL-1β,TNF-
α, and COX-2 by immunohistochemical staining [48–50].4 Infectious Diseases in Obstetrics and Gynecology
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Figure 1:RoadstoPreterm.Birthpathogensmayentertheplacental
blood supply via systemic circulation due to previous or current
onset of infection. Murine models where intraperitoneal injections
are employed are utilized to mimic maternal systemic infection
in order to study the ability of a pathogen to activate decidual
immunity. Data presented in this paper demonstrate that systemic
infections correlate to TNF-α-dependent immune responses that
ultimately induce preterm birth. In contrast, intrauterine ascending
infections occur when a pathogen ascends the uterine cavity via the
vaginal tract. Surgical procedures in mice, rats, and rabbits have
mimicked uterine cavity infections through intrauterine infusion
of pathogens directly into the amniotic sac or between two
placental units. Importantly, data summarized here demonstrate
that pathogens introduced through intrauterine ascension do not
tend to activate a TNF-α-driven axis to induce preterm birth.
Furthermore, the presence of bacterial agents can be probed
for by testing the amniotic ﬂuid for microbial invasion of the
amniotic cavity (MIAC). Women undergoing preterm labor
with premature rupture of membranes (PROM) show 34%
positive MIAC pathology. Interestingly, at the time that these
women deliver 75% show positive MIAC pathology. It has
beensuggestedthattheinﬂammatoryatmosphereofpreterm
labor allows for increased bacterial proliferation [44, 51].
5.ViralEntry
Though data is relatively scarce, evidence suggests that viral
entry into trophoblast cells induces trophoblast apoptosis
and the resultant inﬂammatory events can lead to preterm
birth [52]. The general route of entry in placental viral infec-
tions is cell-speciﬁc as diﬀerent viruses enter trophoblasts
that express their viral receptor [42, 52, 53]. Once viral
uncoating or shedding occurs within a cell, intracellular
TLRs are available as sentinels within endosomal pockets
where viruses may replicate. Intracellular TLRs, TLR3,
TLR7/8, and TLR9 are speciﬁc for viral genomic motifs and,
notsurprisingly,areassociatedwithseveralvirusesthatprove
correlation with adverse pregnancy outcomes.
6. TLRs: Sentinels of Uterine Immunity
Here, we summarize known pathogens, viral or bacterial,
associated with induction of preterm birth. We highlight
immunological pathways that demonstrate speciﬁc PAMPs
that activate TLRs to induce preterm birth. Work in mouse
models illustrates diﬀerential TLR-mediated cascades of
inﬂammatory-based uterine immunity that can lead to
preterm birth. Importantly, clinical correlates where amni-
otic ﬂuid is tested or maternal/fetal membranes are probed
begin to support these ﬁndings.
6.1. TLR2. TLR2 is one of the more promiscuous TLRs
in that upon activation it can concomitantly signal with
TLR1 and TLR6. In line with these ﬁndings, TLR2 is not
only speciﬁc for gram positive bacteria due to its speciﬁcity
for peptidoglycan, but also signals upon recognition of
meningococcal porins, fungal, parasitic, and viral pathogen-
associatedmolecularpatterns[12].Studiesshowthatwomen
who deliver preterm with the condition of chorioamnionitis
show signiﬁcant upregulation of the TLR2 receptor as
compared to controls, implicating a role for the receptor in
preterm birth and infection [54]. Murine studies demon-
strate preterm birth occurs when TLR2 is activated either
through systemic or intrauterine delivery ([11], our unpub-
lished data). Systemic activation induces activation of the
NF-κB transcription factor, and ﬁrst trimester trophoblasts
produce signiﬁcant amounts of IL-8 and IL-6 ultimately
undergoing apoptosis [12]. In contrast, intrauterine delivery
ofTLR2agonistsdidnotinduceincreasedTNF-αproduction
or NF-κBa c t i v a t i o n[ 11]( T a b l e1).
TLR2-speciﬁc human pathogens that correlate with
increased incidence of preterm birth are ureaplasma ureatic-
ulum,g r o u pBstreptococcus, and cytomegalovirus (CMV)
[55, 56]. Ureaplasma ureaticulum is one of three bacteria that
are grouped together and termed bacterial vaginosis. While
common genital infections such as Chlamydia trachomatis
and neisseria gonorrhoea are rarely associated with aberrant
pregnancy outcomes, high loads of bacterial vaginosis in
pregnant women prove nine times more likely to lead to
prematurity [47]. Thus, the activity of TLR2 in the presence
of ureaplasma ureaticulum is an important correlation in
the literature to follow at the clinical level. CMV shows
the greatest correlation of human infection and adverse
pregnancy outcomes as this herpes virus is present in 80% of
the general population, but becomes active under conditions
ofimmunesuppression.DatademonstratethathumanCMV
may infect syncitiotrophobalsts or cytotrophoblasts and
induce proinﬂammatory cascades such as IL-8 production
[57, 58].
6.2. TLR3. While TLR2 generally “sees” pathogens that are
extracellular, TLR3 possesses speciﬁcity for double stranded
RNA viral motifs and is found in endosomal pockets.Infectious Diseases in Obstetrics and Gynecology 5
Table 1:RoutesofpathogenicentrycoupledtospeciﬁcTLRactivationsleadtopretermbirthviaNF-κB-TNF-α-dependentandindependent
pathways.
TLR (PAMP) Route of Entry NF-κBT N F - α Pregnancy Outcome
TLR2 peptidogylcan IU −− Preterm Birth11
TLR3 poly(I:C) IU −−Preterm Birth
11, up
TLR3 poly(I:C) Systemic + + Preterm Birth60
TLR4 LPS/E. coli IU N/A − Preterm Birth
up
TLR4 LPS/E. coli Systemic N/A ++ Preterm Birth13
TLR9 CpG IU N/A − Preterm Birth/IUFD
up
TLR9 CpG Systemic N/A ++ Preterm Birth/IUFD15
– up is our unpublished data
Recently, it was shown that TLR3 can recognize products
of cellular necrosis, a fact of importance for a system such
as pregnancy where cellular turnover is abundant [59].
Evidence suggests that TLR3 activation in trophoblasts may
be a key mechanism to preterm birth outcome induced by
infectious agents [60].
Trophoblasts express the coxsackievirus and adenovirus
receptor (CAR). Upon adenoviral infection, trophoblasts
underwent apoptosis and this led to recruitment of a
decidual immune response [42]. Studies in human and
mouse trophoblast cells show that cells were treated with
syntheticTLR3ligandpoly(I:C),andtheNF-κBpath wa ywas
activated leading to downstream cascades of inﬂammatory
signals. Studies have utilized poly(I:C) as well to assess the
role of preterm birth through TLR3 activation in mouse
models. Where poly(I:C) was injected intraperitoneally to
mimic a maternal systemic infection, mice gave preterm
birththroughanNK-κB-dependentmechanismanddemon-
strated marked serum and placental production of IL-
6, IL-12, and MCP-1 [11, 60]. Our unpublished results
demonstrate that preterm birth in WT mice is induced by a
TNF-α-mediated axis. In contrast, in a model of intrauterine
infusion, INF-β and CCL5 were the major contributors to
preterm birth outcomes in response to poly(I:c) and TNF-
α production was not signiﬁcant [11]. Taken together, these
studies lend evidence to the hypothesis that route of entry
of a virus may play a role in the speciﬁcity of the immune
response evoked (Table 1).
6.3. TLR4. It is well established that TLR4 recognizes
lipopolysacharride motifs found on the majority of gram
negativebacteria.Twoofthethreebacterialstrainsassociated
with preterm birth outcomes, mycoplasma hominis and
trachtomonas vaginalis, are gram negative and thus have the
capacity to signal via TLR4 [46]. Activation of TLR4 at the
placentallevel hasbeen studied in order to assessthe possible
immune activation that ensues when TLR4 speciﬁc bacterial
loads overwhelm the uterine cavity and trigger preterm
birth [61]. Our lab has demonstrated that LPS and E. coli
causeincreaseduNKcellcytotoxicityandTNF-αproduction,
ultimately leading to preterm birth. Neutralization of TNF-
α or abolition of uNK cells rescued pregnancy to term.
In contrast, our unpublished model of E. coli intrauterine
infusion demonstrates that preterm birth does occur, but not
inaTNF-α-dependentmanner([13],ourunpublisheddata).
Similar unpublished data from our lab agree with this data as
the NF-κBp a t h w a yw a sn o ta c t i v a t e di nam o d e lo fp r e t e r m
birthmediatedbyLPSintrauterineinfusion(Table1).Again,
these results present strong evidence for the hypothesis that
alternative routes of pathogenic entry, for both viral and
bacterial pathogens, can cause markedly diﬀerent immune
responses, both ultimately leading to preterm birth.
6.4. TLR7/8. TLR7/8 are speciﬁc for single stranded RNA
motifs, thus retroviruses are strong candidates to activate
thesereceptors.ThoughHIVisnotyetcorrelatedtoaspeciﬁc
TLR for activation, evidence suggests that TLR7 activation
mimics HIV related pathologies [62]. Importantly, strong
associations exist between HIV seroprevalance and incidence
of preterm birth. A cohort study that followed 600 women,
approximately half seropositive for HIV and half seronega-
tive, showed that HIV+ women were signiﬁcantly more likely
to give preterm birth. Furthermore, the seropositive women
who gave preterm birth showed signiﬁcantly diminished
levels of CD4+ T cells [63]. Taken together, these data
demonstrate that either HIV or the immune-compromised
state of mothers may lead to increased risk of preterm birth.
Studies in nonpregnant patients aim to activate TLRs in
order to discourage HIV activity due to the proinﬂammatory
activity of antiretroviral therapy [64]. Taken together, the
immunosuppressive state of pregnancy needs to be thor-
oughly considered when therapy is employed in pregnant
women, but lessons may be learned from how the virus
travels and replicates during this state.
6.5. TLR9. TLR9 recognizes unmethylated CpG motifs.
Though reports identify this intracellular receptor as speciﬁc
for double stranded DNA viruses or fetal DNA, these
types of CpG motifs constitute over 80% of bacterial
genomes as well. Studies that activate TLR9 with CpG in
pregnant mice thus far have demonstrated that a lack of IL-
10 causes high susceptibility to CpG-mediated pathogenic
mimics and inﬂammatory responses composed of severe
placentalmacrophageandneutrophilinﬂuxcoupledtoTNF-
α production and preterm birth [15]( T a b l e1).
The family of herpes viruses is associated with TLR9
activation and reports demonstrate that active viral shedding
during pregnancy is associated with preterm birth outcomes.6 Infectious Diseases in Obstetrics and Gynecology
Importantly, since herpes viruses are latent or chronic, if
the virus is inactive during the term of pregnancy there
are no signiﬁcant ﬁndings that viral carriers have adverse
pregnancy outcomes [65]. While cytomegalovirus belongs to
the herpes virus family, it has been associated with activation
of TLR2 in humans, while murine CMV is speciﬁc for TLR9.
Mouse models demonstrate that CpG motifs speciﬁc for
TLR9 activation do lead to adverse pregnancy outcomes in
IL-10/ mice [15]. In wild type mice, the adverse eﬀects were
on nonlive born pups that experienced cranial-facial and
distal limb malformation [66]. Interestingly, infants born to
CMV-infected mothers have shown similar malformations
[67].
7. Conclusion
Taken together, the aforementioned studies and resultant
data demonstrate that pathogenic route of entry as well
as the speciﬁc TLR activated may be two important deter-
minants of the immune responses that induce preterm
birth. Murine studies have begun to delve into the role of
NF-κB and its direct role in TNF-α production. Impor-
tantly, an amassment of current literature seems to suggest
that systemic inﬂammatory responses may induce TNF-α
through the NF-κB pathway to activate events leading to
preterm birth. In contrast, in the intrauterine setting the
modeofactionismostlikelyTNF-α-independent.Therefore,
more research needs to occur to better understand the
underlying inﬂammatory or hormonal imbalances that are
induced by intrauterine infection that lead to preterm birth
outcomes.
In regards to activation of speciﬁc TLRs, systemic
injection of diﬀerent PAMPs demonstrates that alternative
immune cell subsets respond based on the pathogen at
play. Bacterial pathogens signaling through TLR2 or TLR4
show strong staining within human chorion and amnion
membranes. Murine studies emphasize the role of uNK cell
ampliﬁcation and TNF-α production in response to TLR4
activation. TLR3 activation data from our lab demonstrates,
in WT mice, that uNK cells amplify and produce TNF-
α in response to poly(I:C), a viral mimic. Importantly,
other reports show that systemic injection of poly(I:C)
induces trophoblast apoptosis after a vigorous cytokine
storm lending to a preterm birth outcome. Taken together,
these two reports are not disparate. Finally, in the context
of TLR9 activation it has been shown that macrophages and
neutrophils inﬁltrate the placental zone and lead to preterm
birth or intrauterine fetal death outcomes.
Asawhole,thereportsdiscussedinthispaperlendstrong
evidence to the postulate that the pathway to induction of
preterm birth is dependent on the TLR activated—a product
of the type of pathogenic infection. Secondly, the route of
entry, intrauterine ascension versus systemic infection, plays
a role in determining the cytokine proﬁle activated and
the ensuing mechanism of fetal rejection. From a clinical
standpoint, it may be paramount to account for not only
the type of infectious agent at play within the maternal-fetal
system, but also the route through which the pregnancy was
compromised.
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